| Q2 2024 |
64 |
$242M |
+$98.6M |
-$71.3M |
+$27.3M |
VERA, ADMA, XENE, ITCI, SRPT
|
13F-HR |
8/14/2024, 08:55 PM |
| Q1 2024 |
67 |
$224M |
+$94M |
-$43.9M |
+$50M |
VERA, XENE, AXSM, ADMA, ALIM
|
13F-HR |
5/15/2024, 11:13 AM |
| Q4 2023 |
62 |
$145M |
+$65M |
-$111M |
-$45.7M |
XENE, ALIM, AXSM, BOXX, VERA
|
13F-HR |
2/14/2024, 10:20 AM |
| Q3 2023 |
65 |
$173M |
+$78.9M |
-$28.8M |
+$50.2M |
CBAY, IMGN, ATXS, XTNT, AMLX
|
13F-HR |
11/14/2023, 10:58 AM |
| Q2 2023 |
63 |
$128M |
+$59.6M |
-$102M |
-$42.8M |
KDNY, ATXS, IMGN, ADMA, XENE
|
13F-HR |
8/14/2023, 05:20 PM |
| Q1 2023 |
88 |
$167M |
+$60.2M |
-$87.4M |
-$27.2M |
ATXS, ADMA, BLU, KDNY, AMLX
|
13F-HR |
5/15/2023, 11:45 AM |
| Q4 2022 |
91 |
$195M |
+$55.8M |
-$147M |
-$91.2M |
ATXS, ADMA, KDNY, BLU, PEPL
|
13F-HR |
2/14/2023, 10:23 AM |
| Q3 2022 |
130 |
$265M |
+$84M |
-$71.5M |
+$12.5M |
BLU, KDNY, CCXI, PEPL, ADMA
|
13F-HR |
11/14/2022, 10:53 AM |
| Q2 2022 |
120 |
$236M |
+$80.7M |
-$102M |
-$21.8M |
KDNY, BLU, ADMA, ESPR, PEPL
|
13F-HR |
8/15/2022, 04:00 PM |
| Q1 2022 |
117 |
$287M |
+$83.6M |
-$138M |
-$54.1M |
ESPR, BLU, PTGX, KDNY, PEPLU
|
13F-HR |
5/16/2022, 04:20 PM |
| Q4 2021 |
131 |
$356M |
+$128M |
-$133M |
-$5.14M |
ESPR, PTGX, BLU, BCYC, CRNX
|
13F-HR |
2/14/2022, 05:08 PM |
| Q3 2021 |
121 |
$375M |
+$105M |
-$148M |
-$43M |
POLWS, BLU, CLDX, CTIC, ALDX
|
Restatement |
11/17/2021, 12:04 PM |
| Q2 2021 |
135 |
$429M |
+$196M |
-$128M |
+$67.6M |
POLWS, XTNT, PTGX, CRNX, ALDX
|
13F-HR |
8/13/2021, 04:59 PM |
| Q1 2021 |
124 |
$360M |
+$183M |
-$103M |
+$80M |
CRIS, VRCA, BIOR, CHAQ, EPIX
|
13F-HR |
5/5/2021, 07:32 PM |
| Q4 2020 |
94 |
$268M |
$0 |
$0 |
|
OCUP, CRIS, OCUL, ISEE, STRO
|
Restatement |
5/5/2021, 08:47 AM |